Delivery Order SPE2DB24D2205-SPE2DB25FEATK

Award Date 4/9/25
Potential Completion Date 4/10/25
Potential Value $7.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,231.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of Lyrica 100 mg capsules, a medication used to treat various conditions including neuropathic pain, fibromyalgia, and seizures. The contract is a Delivery Order issued under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This federal contract award, valued at $12,109.26, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lyrica 100 mg capsules, a prescription medication used to treat certain types of nerve pain. The award is a Firm Fixed Price Delivery Order with a completion date of February 26, 2025. This contract is not designated as a set-aside and appears to be part of a...
This federal contract award, valued at $5,236.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lyrica 100 mg capsules, a medication used to treat various conditions such as neuropathic pain, fibromyalgia, and epilepsy. The contract is a Firm Fixed Price Delivery Order with a completion date of March 7, 2025. This award is not associated with a set-aside...
This federal contract award, valued at $1,778.47, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lyrica 100 mg capsules. The contract is a delivery order with a firm fixed price, and the ultimate completion date is March 26, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $2,905.99, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the supply of Lyrica 300 mg capsules, a medication used for the treatment of neuropathic pain, nerve pain, and fibromyalgia. The contract has an ultimate completion date of December 30, 2024 and is a Firm Fixed Price arrangement. This award is part of a larger Indefinite Delivery Contract...
This federal contract award, valued at $8,867.14, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lyrica 50 mg capsules, a prescription medication used to treat certain types of nerve pain. The contract has an ultimate completion date of December 14, 2023 and is structured as a Firm Fixed Price Delivery Order. It is not designated as a set-aside contract....
This federal contract award, valued at $1,044.74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lyrica 50 mg capsules, a medication used to treat various conditions including neuropathic pain, seizures, and fibromyalgia. The contract has a firm fixed price and is a delivery order with a completion date of December 22, 2023. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,040.28 firm fixed-price delivery order is for the supply of Lyrica 100 mg capsules, a medication used to treat various conditions such as neuropathic pain, fibromyalgia, and seizures. The contract is not designated as a set-aside award, indicating open competition. It is part of a larger Indefinite Delivery...
This federal contract award, valued at $10,862.96, was issued by the Defense Logistics Agency to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lyrica 50 mg capsules, a medication used to treat certain types of nerve pain. This contract is a delivery order, with a firm fixed price pricing type, and has an ultimate completion date of January 25, 2024. The contract is not designated as a set-aside and is part...
This federal contract award, valued at $2,736.03, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Lyrica 50 mg capsules, a medication commonly used for the treatment of neuropathic pain, fibromyalgia, and other conditions. The contract has an ultimate completion date of January 9, 2024 and a firm fixed-price pricing structure. This award is...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FEATK
    Delivery Order

This federal contract award, valued at $7,286.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lyrica 100 mg capsules, a medication used to treat conditions such as neuropathic pain.

The contract is structured as a delivery order, with a firm fixed price pricing type and an ultimate completion date of April 10, 2025. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

Generated 7/9/25, 9:48 AM